Zi Long Qian

Chief Executive Officer at SHENZHEN KINGSINO TECHNOLOGY CO.,LTD.

Net worth: 177 726 $ as of 2024-04-29

37 year

18 connections

Consumer Services

Health Technology

Process Industries

Profile

Zi Long Qian is currently the Director at Wuhan Huayang Animal Pharmaceutical Co., Ltd.
and the General Manager at Shenzhen Kingsino Technology Co., Ltd.
He has an undergraduate degree from China University of Geosciences and an MBA from Sun Yat-Sen University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
SHENZHEN KINGSINO TECHNOLOGY CO., LTD. CLASS A 0.05%	2023-08-25	292,500 ( 0.05% )	177 726 $	2024-04-29

Zi Long Qian active positions

Companies	Position	Start
SHENZHEN KINGSINO TECHNOLOGY CO.,LTD.	Chief Executive Officer	2022-10-27
Wuhan Huayang Animal Pharmaceutical Co., Ltd. Wuhan Huayang Animal Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Huayang Animal Pharmaceutical Co., Ltd. is a private company that manufactures and sells veterinary drugs, aquatic feed drug additives, and aquaculture fertilizer. The company is based in Wuhan, China. Wuhan Huayang Animal Pharmaceutical Co. was acquired by Wuhan Huayang Animal Pharmaceutical Co. Ltd. /Sun/ from Shenzhen Kingsino Technology Co., Ltd. on April 16, 2022 for $24.21 million. The Chinese company was founded in 2000. The CEO is Jin Lin Zhang.	Director/Board Member	-

All active positions of Zi Long Qian

Training of Zi Long Qian

China University of Geosciences	Undergraduate Degree
Sun Yat-Sen University	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Zi Long Qian's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
SHENZHEN KINGSINO TECHNOLOGY CO.,LTD.	Process Industries

Private companies	1
Wuhan Huayang Animal Pharmaceutical Co., Ltd. Wuhan Huayang Animal Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Huayang Animal Pharmaceutical Co., Ltd. is a private company that manufactures and sells veterinary drugs, aquatic feed drug additives, and aquaculture fertilizer. The company is based in Wuhan, China. Wuhan Huayang Animal Pharmaceutical Co. was acquired by Wuhan Huayang Animal Pharmaceutical Co. Ltd. /Sun/ from Shenzhen Kingsino Technology Co., Ltd. on April 16, 2022 for $24.21 million. The Chinese company was founded in 2000. The CEO is Jin Lin Zhang.	Health Technology